4basebio

4BB · AIM · Health Care · mcap £87m · 562.5p

Beta Briefing, track record and signals & risks are not ready for 4basebio yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 28 Sep 26 ↗

Revenue: £781k
Operating profit: –
Net income: –
Free cash flow: −£18.4m
Net debt: £8.3m
Market cap: £87.4m
EV / EBIT: –
FCF yield: −21.1%
Price / book: 68.8×

Latest half-year · H1 26 vs H1 25 results 28 Sep 26 ↗

Revenue: £262k
Net income: −£8.9m
Cash from operations: −£8.4m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

As reported Key figures

Income statement Balance sheet Cash flow

Annual Half-yearly

Every line as the company printed it, newest first – each period in the latest version the company published (restated figures where a later report restated them), in its own currency and units. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.

Latest report: H1 26 (six months to 30 Jun 26), published 28 Sep 26 · read the results ↗

The income statement could not be read from the annual results announcements – see Key figures.

	30 Jun 26 source
Assets
Intangible assets	4,973
Property, plant and equipment	4,660
Other non-current assets	242
Total non-current assets	9,875
Current assets
Inventory	775
Trade receivables	845
Other current assets	1,569
Cash and cash equivalents	14,052
Total current assets	17,241
Total assets	27,116
Liabilities
Trade payables	(685)
Lease liabilities	(112)
Other current liabilities	(2,048)
Other financial liabilities	(36)
Total current liabilities	(2,881)
Non-current liabilities
Financial liabilities	(22,310)
Lease liabilities	(645)
Other liabilities	(9)
Total non-current liabilities	(22,964)
Total liabilities	(25,845)
Net assets	1,271
Equity
Share capital	13,799
Share premium	37,254
Capital reserves	14,307
Foreign exchange reserve	(227)
Merger reserve	688
Accumulated losses	(64,550)
Total equity	1,271

	30 Jun 26 source	30 Jun 25 source
Assets
Intangible assets	4,973	4,825
Property, plant and equipment	4,660	4,027
Other non-current assets	242	33
Total non-current assets	9,875	8,885
Current assets
Inventory	775	657
Trade receivables	845	289
Other current assets	1,569	1,915
Cash and cash equivalents	14,052	17,803
Total current assets	17,241	20,664
Total assets	27,116	29,549
Liabilities
Trade payables	(685)	(1,052)
Lease liabilities	(112)	(130)
Other current liabilities	(2,048)	(1,607)
Other financial liabilities	(36)	(39)
Total current liabilities	(2,881)	(2,828)
Non-current liabilities
Financial liabilities	(22,310)	(15,645)
Lease liabilities	(645)	(691)
Other liabilities	(9)	(274)
Total non-current liabilities	(22,964)	(16,610)
Total liabilities	(25,845)	(19,438)
Net assets	1,271	10,111
Equity
Share capital	13,799	13,799
Share premium	37,254	37,254
Capital reserves	14,307	14,151
Foreign exchange reserve	(227)	(155)
Merger reserve	688	688
Accumulated losses	(64,550)	(55,626)
Total equity	1,271	10,111

	H1 26 source	H1 25 source
Cash flows from operating activities
Loss for the period	(8,924)	(7,804)
Adjustments for
Tax charge	(271)	(418)
Tax received	492	324
Depreciation of property, plant and equipment	445	469
Amortisation of capitalised development costs and patents	126	106
Share-based payment charge	155	195
Foreign exchange adjustments	-	-
Other operational foreign exchange and non-cash items	(36)	-
Net finance (income)/costs	279	(165)
Changes in working capital
(Increase)/decrease in inventories	(123)	(150)
(Increase)/decrease in trade receivables and other current assets	(400)	296
Increase/(decrease) in trade payables and other current liabilities	(155)	(1,015)
Net cash flow from operating activities	(8,412)	(8,162)
Cash flows from investing activities
Investments in property, plant and equipment	(1,077)	(322)
Investments in capitalised development and intangible assets	(371)	(320)
Interest received	162	556
Net cash flow from investing activities	(1,286)	(86)
Cash flows from financing activities
Proceeds from issue of equity (net of expenses)	-	-
Proceeds from exercise of share options	-	16
Drawdowns under loan facility	6,037	-
Repayments under loan facility	(43)	(227)
Lease liability repayments (IFRS	(63)	(58)
Interest paid	-	(35)
Cash flows from financing activities	5,931	(304)
Net (decrease)/increase in cash and cash equivalents	(3,767)	(8,552)
Foreign exchange differences	16	62
Cash and cash equivalents at the beginning of the period	17,803	34,604
Cash and cash equivalents at the end of the period	14,052	26,114

	LTM Jun 26	FY 25
Revenue to operating profit
Revenue	0.8	1.7
Depreciation (owned assets)	0.9	0.9
Amortisation	0.2	0.2
Share-based payments	0.2	0.3

	H1 26	vs H1 25	H2 25	H1 25
Revenue to operating profit
Revenue	0.3	−78%	0.5	1.2
Depreciation (owned assets)	0.4	−5%	0.5	0.5
Amortisation	0.1	+19%	0.1	0.1
Share-based payments	0.2	−21%	0.1	0.2
Operating profit to net income
Net income (owners)	(8.9)	–	–	–

	LTM Jun 26	FY 25
Operating activities
Cash from operations	(15.8)	(15.6)
Interest paid	(0.0)	(0.1)
Investing activities
Capex (PP&E)	(1.2)	(0.5)
Capex (intangibles)	(1.2)	(1.2)
Financing activities
Lease principal paid	(0.1)	(0.1)
Shares issued	0.0	0.0

	H1 26	vs H1 25	H2 25	H1 25
Operating activities
Cash from operations	(8.4)	n/m	(7.4)	(8.2)
Interest paid	0.0	n/m	(0.0)	(0.0)
Investing activities
Capex (PP&E)	(1.1)	+234%	(0.1)	(0.3)
Capex (intangibles)	(0.4)	+16%	(0.8)	(0.3)
Financing activities
Lease principal paid	(0.1)	n/m	(0.1)	(0.1)
Shares issued	0.0	n/m	0.0	0.0

	30 Jun 26	31 Dec 25
Non-current assets
Property, plant & equipment	4.7	4.0
Non-current assets	9.9	8.9
Current assets
Inventories	0.8	0.7
Cash	14.1	17.8
Current assets	17.2	20.7
Total assets	27.1	29.5
Current liabilities
Trade payables	0.7	1.1
Lease liabilities, current	0.1	0.1
Current liabilities	2.9	2.8
Non-current liabilities
Borrowings, non-current	22.3	15.6
Lease liabilities, non-current	0.6	0.7
Non-current liabilities	23.0	16.6
Total liabilities	25.8	19.4
Equity
Total equity	1.3	10.1

	30 Jun 26	31 Dec 25
Non-current assets
Property, plant & equipment	4.7	4.0
Non-current assets	9.9	8.9
Current assets
Inventories	0.8	0.7
Cash	14.1	17.8
Current assets	17.2	20.7
Total assets	27.1	29.5
Current liabilities
Trade payables	0.7	1.1
Lease liabilities, current	0.1	0.1
Current liabilities	2.9	2.8
Non-current liabilities
Borrowings, non-current	22.3	15.6
Lease liabilities, non-current	0.6	0.7
Non-current liabilities	23.0	16.6
Total liabilities	25.8	19.4
Equity
Total equity	1.3	10.1

Read automatically from each results announcement. Check the source before relying on a figure.

Company filings. Not investment advice.